(Total Views: 238)
Posted On: 12/05/2017 6:21:58 PM
Post# of 40991
good comparison millaire although imo ONCI has
far more upside potential than RXMD simply
because ONCI growth rate is MUCH HIGHER
and its products serve a MULTI BILLION dollar
Worldwide market where RXMD has limited growth
and only in USA so far.
But the point about making it to OTCQB status
with AUDITED FINANCIALS and how that alone can
move up a stock price dramatically especially when
its chart is oversold like RXMD was is a good one.
You can take it to the bank CEO BERMAN knows
ONCI will trade WAY WAY over .01 in 2018 to
qualify for OTCQB status !
far more upside potential than RXMD simply
because ONCI growth rate is MUCH HIGHER
and its products serve a MULTI BILLION dollar
Worldwide market where RXMD has limited growth
and only in USA so far.
But the point about making it to OTCQB status
with AUDITED FINANCIALS and how that alone can
move up a stock price dramatically especially when
its chart is oversold like RXMD was is a good one.
You can take it to the bank CEO BERMAN knows
ONCI will trade WAY WAY over .01 in 2018 to
qualify for OTCQB status !
(1)
(0)
